224 related articles for article (PubMed ID: 30031760)
1. Lifecycle modelling systems support inosine monophosphate dehydrogenase (IMPDH) as a pro-viral factor and antiviral target for New World arenaviruses.
Dunham EC; Leske A; Shifflett K; Watt A; Feldmann H; Hoenen T; Groseth A
Antiviral Res; 2018 Sep; 157():140-150. PubMed ID: 30031760
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Junin virus RNA synthesis by an antiviral acridone derivative.
Sepúlveda CS; García CC; Fascio ML; D'Accorso NB; Docampo Palacios ML; Pellón RF; Damonte EB
Antiviral Res; 2012 Jan; 93(1):16-22. PubMed ID: 22027649
[TBL] [Abstract][Full Text] [Related]
3. Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.
Tong X; Smith J; Bukreyeva N; Koma T; Manning JT; Kalkeri R; Kwong AD; Paessler S
Antiviral Res; 2018 Jan; 149():34-40. PubMed ID: 29126899
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
5. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.
Zhou S; Liu R; Baroudy BM; Malcolm BA; Reyes GR
Virology; 2003 Jun; 310(2):333-42. PubMed ID: 12781720
[TBL] [Abstract][Full Text] [Related]
6. Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.
Leske A; Waßmann I; Schnepel K; Shifflett K; Holzerland J; Bostedt L; Bohn P; Mettenleiter TC; Briggiler AM; Brignone J; Enria D; Cordo SM; Hoenen T; Groseth A
Antiviral Res; 2019 Mar; 163():106-116. PubMed ID: 30668977
[TBL] [Abstract][Full Text] [Related]
7. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
[TBL] [Abstract][Full Text] [Related]
8. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of A771726, the active metabolite of leflunomide, against Junín virus.
Sepúlveda CS; García CC; Damonte EB
J Med Virol; 2018 May; 90(5):819-827. PubMed ID: 29315647
[TBL] [Abstract][Full Text] [Related]
10. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inosine monophosphate dehydrogenase (IMPDH) by the antiviral compound, 2-vinylinosine monophosphate.
Pal S; Bera B; Nair V
Bioorg Med Chem; 2002 Nov; 10(11):3615-8. PubMed ID: 12213477
[TBL] [Abstract][Full Text] [Related]
12. T-705 (favipiravir) inhibition of arenavirus replication in cell culture.
Mendenhall M; Russell A; Juelich T; Messina EL; Smee DF; Freiberg AN; Holbrook MR; Furuta Y; de la Torre JC; Nunberg JH; Gowen BB
Antimicrob Agents Chemother; 2011 Feb; 55(2):782-7. PubMed ID: 21115797
[TBL] [Abstract][Full Text] [Related]
13. A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5'-Monophospate Dehydrogenase activity.
Hu J; Ma L; Wang H; Yan H; Zhang D; Li Z; Jiang J; Li Y
Virol J; 2017 Mar; 14(1):55. PubMed ID: 28298229
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Innate Immune Responses to Pathogenic and Nonpathogenic Clade B New World Arenaviruses.
Moreno H; Möller R; Fedeli C; Gerold G; Kunz S
J Virol; 2019 Oct; 93(19):. PubMed ID: 31270228
[TBL] [Abstract][Full Text] [Related]
15. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
Stuyver LJ; Lostia S; Patterson SE; Clark JL; Watanabe KA; Otto MJ; Pankiewicz KW
Antivir Chem Chemother; 2002 Nov; 13(6):345-52. PubMed ID: 12718406
[TBL] [Abstract][Full Text] [Related]
17. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
18. A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.
Ziegler CM; Eisenhauer P; Kelly JA; Dang LN; Beganovic V; Bruce EA; King BR; Shirley DJ; Weir ME; Ballif BA; Botten J
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187543
[TBL] [Abstract][Full Text] [Related]
19. Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016).
Cuny GD; Suebsuwong C; Ray SS
Expert Opin Ther Pat; 2017 Jun; 27(6):677-690. PubMed ID: 28074661
[TBL] [Abstract][Full Text] [Related]
20. A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR).
King BR; Hershkowitz D; Eisenhauer PL; Weir ME; Ziegler CM; Russo J; Bruce EA; Ballif BA; Botten J
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]